Study ID | Study follow‐up (months) | FINLAY‐FR‐2 (n) | Placebo (n) | Critical outcomes | ||||||
Confirmed SARS‐CoV‐2 infection after complete vaccination | Confirmed symptomatic COVID‐19 after complete vaccination | Severe or critical COVID‐19 | All‐cause mortality | Systemic reactogenicity events | Any AE | SAE | ||||
Toledo‐Romani 2021 (RPCEC00000354) | 5.2 | 14,679 | 14,675 | X | ✓ | ✓ | ✓ | * | X | * |